Approval · Notice of Compliance 14078 · 2013
CLOPIDOGREL: Notice of Compliance 14078
Issued February 11, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14078
- Date
- February 11, 2013
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Platelet aggregation inhibitor
- Canadian reference product
- PLAVIX
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLOPIDOGREL | 02400553 | Marketed |
Medicinal ingredients
- CLOPIDOGREL BISULFATE 75 MG per TAB